Are you aged between 65-85?
We are testing an investigational vaccine for its effectiveness against diseases caused by respiratory syncytial virus (RSV).
Respiratory syncytial virus (RSV) is a common virus that causes lower respiratory infections. Most people recover quickly from these infections, but infants and young children, older adults and anyone with a compromised immune system may be at greater risk for more severe infections.
In order to complete this study, we need volunteers from the public. You may be eligible for this study if you are:
- aged 65-85
- in relatively good health
- willing and able to follow a study treatment plan for approximately 12 months
You will be medically supervised and there will be no costs involved. For more information, with no obligation, please call:
Kate – Clinical Research Coordinator (02) 4963 2323 (take option 1).
Please do leave a message with your name and contact details so we can return your call.
This study has Human Research Ethics Committee (HREC) approval.
Register Your Interest
Please contact us now to learn more about participating in this Clinical Trial.